Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

Abstract Background While the number of therapeutic options for treating inflammatory bowel diseases (IBD) is increasing, evidence for rational treatment decisions is scarce in many cases. In particular, appropriate biomarkers to predict the response to the anti-α4β7 integrin antibody vedolizumab ar...

詳細記述

保存先:
書誌詳細
主要な著者: Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Entcho Klenske, Lisa Müller, Nadine Morgenstern, Konstantin Fietkau, Simon Hirschmann, Raja Atreya, Imke Atreya, Markus F. Neurath, Sebastian Zundler
フォーマット: Artigo
言語:Inglês
出版事項: BMC 2020-04-01
シリーズ:BMC Gastroenterology
主題:
Inflammatory bowel diseases
T cells
Vedolizumab
Adhesion
Gut homing
オンライン･アクセス:http://link.springer.com/article/10.1186/s12876-020-01253-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料